Jade Biosciences is a clinical-stage biotechnology company dedicated to developing innovative therapies for autoimmune diseases. With its lead candidate, JADE101, currently in a Phase 1 clinical trial, Jade is focused on targeting cytokines such as APRIL to meet critical unmet medical needs. The company's promising pipeline also includes preclinical candidates like JADE201 and JADE301, showcasing its commitment to advancing antibody-based treatments.
No jobs found. Subscribe below to get notified when we find something for you.
Searching